Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Skin Cancer01:30

Skin Cancer

6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

16.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

Correction: Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey.

European journal of pediatrics·2026
Same author

Developing an HL7 FHIR Implementation Guide for Rare Cancers: The IDEA4RC Project Experience.

Studies in health technology and informatics·2026
Same author

Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Driven Integration of Ki-67 and Mitotic Count.

Endocrine pathology·2026
Same author

Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study.

European journal of cancer (Oxford, England : 1990)·2026

Related Experiment Video

Updated: Mar 26, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

Thymoma and thymic carcinomas.

Marta Scorsetti1, Francesco Leo2, Annalisa Trama3

  • 1Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy.

Critical Reviews in Oncology/Hematology
|January 29, 2016
PubMed
Summary
This summary is machine-generated.

Thymomas and thymic carcinomas are rare mediastinal tumors. This review covers their clinical management, including surgery, radiotherapy, chemotherapy, and emerging targeted therapies for better patient outcomes.

Keywords:
ChemotherapyDiagnosisRadiotherapySurgeryTargeted therapiesThymic carcinomaThymomas

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.4K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Thymomas (Ts) and thymic carcinomas (TCs) are rare mediastinal neoplasms with low incidence.
  • Histological classification (WHO system) and staging are crucial for prognosis.
  • Current treatment relies on surgery, radiotherapy, and chemotherapy.

Purpose of the Study:

  • To review the key aspects of clinical management for thymomas and thymic carcinomas.
  • To highlight current treatment modalities and their efficacy.
  • To discuss the role of emerging targeted therapies.

Main Methods:

  • Literature review of clinical management strategies for Ts and TCs.
  • Analysis of treatment outcomes based on tumor stage and resection status.
  • Discussion of current therapeutic standards and future directions.

Main Results:

  • Surgery offers good long-term survival for early-stage disease (80% 10-year survival for Stage I).
  • Radiotherapy and platinum-based chemotherapy are vital for advanced or residual disease.
  • Multimodality approaches are recommended when surgery is not feasible.

Conclusions:

  • Effective clinical management of thymomas and thymic carcinomas requires a multidisciplinary approach.
  • While surgery remains primary, radiotherapy and chemotherapy are essential for advanced stages.
  • Further research into molecular aberrations is needed to develop effective targeted therapies.